Drug wholesalers to show a boycott sign against Novartis and Boehringer product sales.

The drug wholesale community intends to reject distribution of Novartis and Boehringer products for the purpose of warning against other pharmaceutical manufacturers who might additionally joint Zuellig for their drug wholesale distributions since the above two foreign invested companies already engaged in their wholesale distribution agreement solely with Zuellig.

The above movement was rai...